Cystatin C and Risk of Diabetes and the Metabolic Syndrome – Biomarker and Genotype Association Analyses

PLoS ONE - United States
doi 10.1371/journal.pone.0155735
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Gamma-Glutamyl Transferase: Another Biomarker for Metabolic Syndrome and Cardiovascular Risk

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2007English

Higher Levels of Cystatin C in HIV/AIDS Patients With Metabolic Syndrome

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Association Between Framingham Risk Score and Metabolic Syndrome in Elderly

Revista Brasileira de Ciências do Envelhecimento Humano
2016English

Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association

Journal of Thyroid Research
EndocrinologyMetabolismDiabetes
2018English

Clinical Analysis of Association of Cystatin C and Atrial Fibrillation

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2014English

Canagliflozin Improves Risk Factors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus and Metabolic Syndrome

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2017English

Association Between C-Reactive Protein and Metabolic Syndrome in Korean Adults

Korean Journal of Family Medicine
Family Practice
2019English

Cystatin C and Sudden Cardiac Death Risk in the Elderly

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2010English

The Risk of Metabolic Syndrome and Nutrition

Obesity and Metabolism
Internal MedicineNutritionEndocrinologyPublic HealthEnvironmentalDieteticsOccupational HealthMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy